Entheon Biomedical
A cutting-edge solution for a trillion dollar problem
Mental disorders, including addiction, are expected to cost $16 trillion globally by 2030. One company is on a mission to help those afflicted.
Leveraging emerging biotechnology, Entheon is pioneering a leading-edge addiction recovery solution that harnesses and optimizes the therapeutic potential of DMT.
- DMT is a powerful treatment for Substance Use Disorder
- The Right Molecule: DMT has been used therapeutically for hundreds of years and disrupts the way our brains respond to stimuli
- The Right Technology: Entheon’s delivery system allows physicians to control the strength and duration of the psychedelic state
- The Right Patient Experience: Individualized approach considers every aspect of the patient journey, including how the individual is informed and prepared, the comfort and ambiance of their treatment environment, and follow-up.
